CLINICAL_TRIALS
trial_result
· 2014-07-11
Clinical Trial Update: Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Summary
A Phase 3 trial comparing Ba253BINEB with Ba253MDI in chronic obstructive pulmonary disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED